Kidney Transplantation Clinical Trials
A listing of Kidney Transplantation medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found 90 clinical trials
BIVV020 in Prevention and Treatment of Antibody-mediated Rejection (AMR)
transplant participants To characterize the pharmacokinetic (PK) profile of BIVV020 in kidney transplant participants To evaluate the immunogenicity of BIVV020
- 16 views
- 25 Jan, 2023
- 20 locations
Janssen Ad26.CoV2.S Vaccine Booster in Kidney Transplant Recipients
The purpose of this research is to see if a dose of the Janssen Ad26.CoV2.S vaccine effects the immune protection in individuals who have had a kidney transplant and two or three doses of mRNA
- 0 views
- 04 Oct, 2022
- 3 locations
A Pivotal Phase 3 Trial to Evaluate the Safety and Efficacy of Clazakizumab for the Treatment of Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients (IMAGINE)
This trial investigates the efficacy and safety of clazakizumab [an anti-interleukin (IL)-6 monoclonal antibody (mAb)] for the treatment of CABMR in recipients of a kidney transplant.
- 142 views
- 25 Oct, 2022
- 69 locations
A Controlled, Open-label PA Efficacy and Safety Study in Imlifidase Desensitised Kidney Tx Patients With Positive XM Against a Deceased Donor Prior to Imlifidase Treatment, Including Non-comparative Registry and Concurrent Reference Cohorts (PAES)
(XM) against a deceased donor prior to desensitized with imlifidase and subsequent kidney transplantation. Two non-comparative reference cohorts are included to assess the impact of differences in
- 0 views
- 16 Oct, 2022
- 6 locations
BIVV020 in Prevention and Treatment of Antibody-mediated Rejection (AMR)
transplant participants To characterize the pharmacokinetic (PK) profile of BIVV020 in kidney transplant participants To evaluate the immunogenicity of BIVV020
- 0 views
- 07 Oct, 2022
- 16 locations
A Double-Blind, Randomized, Placebo-Controlled Phase 2 Clinical Trial To Evaluate Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With Chronic Kidney Disease Stage IV (CKD)
The aim of this Phase 2 study is to evaluate the safety and efficacy of the live biotherapeutic product, KT-301 (formerly US-APR2020), in the management of patients with CKD Stage IV.
- 11 views
- 22 Oct, 2022
- 5 locations
The Effects of Physical Activity Behavior Change in Kidney Transplant Recipients
, physical activity level, physical activity behavior, physical activity barriers and gait parameters in kidney transplant recipients.
- 0 views
- 04 Oct, 2022
- 1 location
Late Abatacept Conversion in Kidney Transplant Recipients Receiving Belatacept: a Prospective, Randomized Controlled Non-inferiority Trial. IM101-884
This is a single center, randomized, controlled phase 2b, conversion trial. This protocol has been developed to answer the question: Can patients be safely converted from monthly belatacept IV infusions to abatacept subcutaneous injections without a decrease in kidney function.The primary objective will be the difference in estimated GFR (eGFR) …
- 0 views
- 27 Oct, 2022
- 1 location
Renal Function in Highly Sensitized Patients 1 Year After Desensitization With Imlifidase Prior to DD Kidney Tx (ConfIdeS)
An open-label, controlled, randomized Phase 3 trial evaluating 12-month kidney function in highly sensitized (cPRA ≥99.9%) kidney transplant patients with positive crossmatch against a deceased
- 0 views
- 04 Oct, 2022
- 10 locations
A Randomized, Controlled, Multi-center, Safety and Efficacy Study of FCR001 Cell-based Therapy Relative to a Tacrolimus and Mycophenolate-based Regimen in de Novo Living Donor Renal Transplant Recipients, and Safety in FCR001 Donors (FREEDOM-1)
A randomized controlled study to evaluate the safety, efficacy, and overall benefit of FCR001 cell therapy in de novo living donor renal transplantation.
- 47 views
- 28 Oct, 2022
- 17 locations